Replies to post #215 on Enumeral Biomedical Holdings Inc fka ENUMQ

[Rkmatters]

Great job. They suggested they may exercise the second part of the agreement by entering into the provision to license another of ENUM's mAB. :)

The 10Q was written with the current cash on hand and the start of these funds brings them into next quarter. If an IND is secured with their anti-PD1 next quarter, then they will begin to see the start of $37.5 million milestone payments. Once a Phase I trial begins, another. Interims then more. :)

That said, I do like how they are writing these SEC reports as they honest about the risk/rewards and so we won't hear complains of how they only have roughly $2.5 million at this point plus NIH grant money, which as part of the Moon Shot program, I expect they will soon be issued more .
Not one larger hold has registered any shares sold. I honestly think we see a TIM-3 agreement with BP next. Just a hunch. :)